Our biostatics team has extensive experience in the design and analysis of clinical trials in a wide range of therapeutic areas.

Solutions are tailored to customers’ requirements include Phase I – IV Clinical Trials, Late Phase / Real World studies, Regulatory Submissions, as well as complex surveys, longitudinal studies, and risk score development.

 We support clinical trials and other research projects from conception to publication. All the analyses use up-to-date and validated software (e.g. SAS and SPSS for statistical analyses) and are performed to ICH GCP standards with emphasis on validation, traceability, and reproducibility.

 

https://www.pharshpharma.com/wp-content/uploads/2020/10/Biostatics-image-840x234.png

 

Our statisticians analyze and design clinical trials across a broad range of therapeutic areas, including, but not limited to:

  • Oncology
  • Cardiology
  • Neurology
  • Respiratory
  • Nephrology
  • Endocrinology
  • Pain Control
  • Infectious Diseases
  • Critical Care
  • Substance Abuse and a diversity of Medical Devices.

Solutions tailored to customers’ requirements include Phase I – IV Clinical Trials, Late Phase / Real World studies, Regulatory Submissions, as well as complex surveys, longitudinal studies, and risk score development.

 

We give first thought to the needs of patients in Sub-Sahara Africa and committed to efforts to train and improve the capacity of all stakeholders to properly conduct clinical trials.

Contact Us